{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-020555","form_type":"8-K","ticker":"MYO","cik":"0001369290","company_name":"MYOMO, INC.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.588590+00:00","generated_at":"2026-06-15T06:05:25.536114+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Myomo Q1 product rev up 20% to $3.4M; record 438 pipeline patients added","bullets":["Product revenue $3.4M, +20% YoY; total revenue $3.4M (-11% due to prior-year license fee).","Record 438 new pipeline patients from previous payers (+54% YoY); total pipeline 855 (+28%).","Cost per pipeline add $1,579 (down 53% YoY, 50% sequentially).","Net loss $2.6M ($0.11 per share) vs $2.8M ($0.43) in Q1 2022.","Guides 20-30% product revenue growth for 2023; cash $11M after April license fee."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-020555","json":"https://secwatch.observer/filing/0000950170-23-020555.json","markdown":"https://secwatch.observer/filing/0000950170-23-020555.md","text":"https://secwatch.observer/filing/0000950170-23-020555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/0000950170-23-020555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/myo-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T06:05:25.536114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"db697a272ce79f312c50aa0e29d70f50b7e86c38","claim":"MYOMO, INC. reported financial results for the three months ended March 31, 2023.","evidence_excerpt":"On May 10, 2023, Myomo, Inc, (the \"Company\") announced its financial results for the first quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023020555/0000950170-23-020555-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}